{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-027229","form_type":"8-K","ticker":"CBUS","cik":"0001705843","company_name":"Cibus, Inc.","filed_at":"2026-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.950384+00:00","generated_at":"2026-05-16T07:03:22.454442+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cibus Updates Business Outlook in 8-K, Projects >$200M Annual Royalties from Rice Traits","bullets":["Cibus estimates over $200 million potential annual addressable royalties from Rice herbicide tolerance traits in the US and Latin America.","Company reduced workforce by approximately 34 full-time employees by December 31, 2025, to streamline focus on Rice program.","Anticipates annual net cash usage of $30 million or less during 2026 following cost reduction actions.","Biofragrance products program could reach $20-40 million annual revenue over a long-term horizon, with initial payments received in 2025.","EU trilogue on New Genomic Techniques positively concluded in December 2025, creating a regulatory path for gene-edited plants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-027229","json":"https://secwatch.observer/filing/0001193125-26-027229.json","markdown":"https://secwatch.observer/filing/0001193125-26-027229.md","text":"https://secwatch.observer/filing/0001193125-26-027229.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1705843/000119312526027229/0001193125-26-027229-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1705843/000119312526027229/d210187d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T07:03:22.454442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}